Objective-Elevated lipoprotein(a) [Lp(a)] is a causal, independent risk factor for cardiovascular disease and aortic stenosis.We aimed to define the prevalence and patient thresholds of elevated Lp(a) levels in the United States. Approach and Results-We analyzed Lp(a) levels in 532 359 subjects from 2 data sets: (1) in 531 144 subjects from a referral laboratory and (2) in 915 patients from a tertiary referral center. Lp(a) mass levels were measured by immunoturbidometric assays in both centers and expressed as mg/dL. At the referral laboratory, the median age (interquartile range) of the subjects was 57.0 (46-67) years, and 51.9% were female. Lp(a) levels were skewed rightward as expected. The mean±SD levels were 34.0±40.0 mg/dL, and median (interquartile range) levels were 17 (7-47) mg/dL, with range 0 to 907 mg/dL. Lp(a) levels at 75%, 80%, 90%, 95%, 99%, and 99.9% percentiles were >47, >60, >90, >116, >180, and >245 mg/dL, respectively. At the referral laboratory, Lp(a) levels >30 and >50 mg/dL were present in 35.0% and 24.0% of subjects, respectively, and at the tertiary referral center, 39.5% and 29.2%, respectively. Females had higher mean (SD) (37.
Results
Data From the Referral LaboratoryRelationship of Lp(a) to Lipid, Lipoprotein, and High Sensitivity C-Reactive Protein Levels Over the 5-year period, a total of 531 144 Lp(a) measurements, with accompanying information on lipid parameters and high sensitivity C-reactive protein (hsCRP), from individual patients in the referral laboratory were available. The median age of all the subjects was 57.0 (46-67), 51.9% were female, and the mean body mass index was 29.7±6.7. Tables 1 and 2 display the relationship of Lp(a) mass, in quintiles and as Lp(a) <30 mg/dL versus >30 mg/dL and <50 mg/dL versus >50 mg/dL, to mean levels of LDL cholesterol (LDL-C), estimated LDL-C corrected for Lp(a) cholesterol, total cholesterol, high-density lipoprotein cholesterol, triglycerides, apoB-100, and non-high-density lipoprotein cholesterol. The mean±SD Lp(a) levels were 34.0±40.0 mg/dL and median (interquartile range) levels were 17 (7-47) mg/dL, with range 0 to 907 mg/ dL. Lp(a) levels at 75%, 80%, 90%, 95%, 99%, and 99.9% percentiles were >47, >60, >90, >116, >180, and >245 mg/dL, respectively. Females had higher mean (SD) (37. Lp(a) levels >30 and >50 mg/dL were present in 35.0% and 24.0% of subjects, respectively. Evaluating Lp(a) in quintiles, LDL-C linearly increased from 99.1 to 108.6 mg/dL. In contrast, removing the Lp(a) cholesterol component of Lp(a) showed that the corrected LDL-C was actually decreasing from 98.1 to 78.5 mg/dL with increasing Lp(a) mass. Total cholesterol, high-density lipoprotein cholesterol, apoAI, and non-high-density lipoprotein cholesterol were all increasing with increasing Lp(a), but triglycerides decreased across quintiles. hsCRP was also increasing linearly with Lp(a) quintiles or Lp(a) cutoffs of >30 and >50 mg/dL (Tables 1 and 2).
Frequency Distribution of Lp(a), LDL-C, and ApoBAs expected, Lp(a) mass levels were skewed rightward (...